Back to search results

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

IsraelRecruitingPHASE2

Conditions

Metastatic Colorectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope National Medical Center /ID# 270255, Duarte, California, United States

  • UCLA - Santa Monica /ID# 270621, Santa Monica, California, United States

  • Yale New Haven Hospital /ID# 270565, New Haven, Connecticut, United States

  • University of Chicago Medical Center /ID# 271688, Chicago, Illinois, United States

  • Hope And Healing Cancer Services /ID# 271562, Hinsdale, Illinois, United States

  • Dana-Farber Cancer Institute /ID# 270624, Boston, Massachusetts, United States

  • Saint Lukes Hospital of Kansas City /ID# 270633, Kansas City, Missouri, United States

  • Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271646, Omaha, Nebraska, United States

  • University of North Carolina Medical Center /ID# 267786, Chapel Hill, North Carolina, United States

  • Oncology Hematology Care - Eastgate /ID# 271493, Cincinnati, Ohio, United States

  • Texas Oncology - Austin Midtown /ID# 271354, Austin, Texas, United States

  • Texas Oncology - Deke Slayton Cancer Center /ID# 271355, Webster, Texas, United States

  • Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax, Virginia, United States

  • Macquarie University /ID# 271514, Sydney, New South Wales, Australia

  • Mater Hospital Brisbane /ID# 270694, South Brisbane, Queensland, Australia

    Study coordinator · +61731632341

  • The Queen Elizabeth Hospital /ID# 270693, Woodville South, South Australia, Australia

  • Austin Health /ID# 270692, Heidelberg, Victoria, Australia

  • One Clinical Research /ID# 270695, Nedlands, Western Australia, Australia

  • Medizinische Universitaet Wien /ID# 268872, Vienna, Austria

  • Hospital Sao Rafael /ID# 271681, Salvador, Estado de Bahia, Brazil

  • Oncosite - Centro de Pesquisa Clinica em Oncologia /ID# 270147, Ijuí, Rio Grande do Sul, Brazil

  • Hospital De Amor /ID# 271874, Barretos, São Paulo, Brazil

  • Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto /ID# 271651, São José do Rio Preto, São Paulo, Brazil

  • Instituto D'Or de Pesquisa e Ensino - Regional Sao Paulo /ID# 270546, São Paulo, Brazil

  • Nucleo De Pesquisa Clinica Da Rede Sao Camilo /ID# 272311, São Paulo, Brazil

  • Fakultni Thomayerova nemocnice /ID# 269632, Prague, Praha, Hlavni Mesto, Czechia

  • Fakultni nemocnice Hradec Kralove - Sokolska /ID# 268773, Hradec Králové, Czechia

  • Chu De Lille - Hopital Claude Huriez /ID# 270222, Lille, Hauts-de-France, France

  • Centre Hospitalier Universitaire de Poitiers /ID# 270225, Poitiers, New Aquitaine, France

  • Hôpital Européen Georges Pompidou /ID# 270224, Paris, France

  • St. Luke's Hospital /ID# 269963, Panórama, Thessaloniki, Greece

  • Theagenio Cancer Hospital /ID# 269640, Thessaloniki, Greece

  • Rabin Medical Center. /ID# 268008, Petah Tikva, Central District, Israel

  • Tel Aviv Sourasky Medical Center /ID# 268010, Tel Aviv, Tel Aviv, Israel

  • Rambam Health Care Campus- Haifa /ID# 268006, Haifa, Israel

  • Shaare Zedek Medical Center /ID# 268009, Jerusalem, Israel

  • Hadassah Medical Center-Hebrew University /ID# 268007, Jerusalem, Israel

  • Aichi Cancer Center /ID# 270113, Nagoya, Aichi-ken, Japan

  • National Cancer Center Hospital East /ID# 270114, Kashiwa-shi, Chiba, Japan

  • St Marianna University School Of Medicine /ID# 270111, Kawasaki-shi, Kanagawa, Japan

  • Tohoku University Hospital /ID# 270966, Sendai, Miyagi, Japan

  • National Cancer Center Hospital /ID# 270112, Chuo-Ku, Tokyo, Japan

  • Pan American Center for Oncology Trials - Rio Piedras /ID# 268809, Rio Piedras, Puerto Rico

  • Puerto Rico Medical Research Center /ID# 268825, San Juan, Puerto Rico

  • Hospital Universitario Marques de Valdecilla /ID# 269732, Santander, Cantabria, Spain

  • Hospital Universitario Vall de Hebron /ID# 270191, Barcelona, Spain

  • Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 269724, Kaohsiung City, Taiwan

  • Kaohsiung Chang Gung Memorial Hospital /ID# 269726, Kaohsiung City, Taiwan

  • National Cheng Kung University Hospital /ID# 270835, Tainan, Taiwan

  • National Taiwan University Hospital /ID# 269717, Taipei, Taiwan

  • Taipei Veterans General Hospital /ID# 269718, Taipei, Taiwan

  • Linkou Chang Gung Memorial Hospital /ID# 269725, Taoyuan City, Taiwan

Study leads

  • ABBVIE INC.

    Study Director

    AbbVie

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)